>CIEIPNNI_00001 Ribosomal RNA large subunit methyltransferase L
MFQLLAVCPMGLEAVVAREIQELGYETNVENGRIFFEGDASAIVKANLWLRTADRIKIVV
GRFNATTFDELFEQTKALPWESIIDKEGNFPVQGRSVKSTLHSVPDCQAITKKAIVERLR
RAYNEKGWLNESGAKYPVEVAILKDNVLLTIDTSGSGLNRRGYRLAQGEAPIKETLAASL
IRLANWKGDTPLIDPFCGSGTIAIEACLIAQNIAPGFNREFVSEQWNIMPANIYDDYRDE
ADKMADYDKEIEVYASDIDPEMVEIAKRNAEEVGLSDIIKFSVKDVNTLTIDTEEPVALI
GNPPYGERIGDREEVEEMYRYIGKLMKQHPFLSTYILTSNKEFEYLVDRKATKRRKLFNG
YIECTYYQYWGKKTERKTIEN
>CIEIPNNI_00002 hypothetical protein
MGLGLSIALVVIGIAVVCLMIFSSQKTTYFGYMNSNTNAEKVVSEKDGLVKHNIKVEPSN
DFKPKKGDFVKLVSKDGGKTFYKQEIVKHDDVPHGLMMKIHDMHMN
>CIEIPNNI_00003 hypothetical protein
MKKFFTFPSVRFFEFEDKKASKTHKKITLLLPNYVIDAFLLIHMHVVNFHH
>CIEIPNNI_00004 hypothetical protein
MKNTFNPLQRLHFYAAIFIAPLLITLTISGIGYLFFPEVENNIYKNKFFGDSDVKTHQTL
NDAVHQVEQQYEGFFVSKVSILDEPYNKRITLSDMAGNQRYVFLDRNNQFVADQNAKHTY
SNVMRSIHSSLFTENTIINYLVELTACWTIFMILSGTYLLIKKHLISNKSKALRWQKWHA
MIGVIIAIPVFVLVITGLPWSGFMGSKIAGMMDTNGDLGQGELAINPPKSDLNELPWATR
KNKQPASSEKGSSGHHGNAAMPQTKLDYQISIDKVVEQAQKSGIKKPFSIVYPSDRNGAF
IVSNTSNSGVTGLDVSPYKEQTLYFDQYSGKKLGTIKYDDYGIIAKWFTWGIPLHEGHLF
GILNKIINLFVCIALLVAIGMGFVSWIKRTKNTAVKVPHRVKKPASISLIICLIVLGLLM
PLFGLSLILVFIIELILYIKDRRAKQ
>CIEIPNNI_00005 GTPase Der
MINKEQLDLLYKLKKEVEKSRNEALLHTINQVIKKVYLQQYTCSFVGHFSAGKSTLINLL
IEQDILPSSPVPTTSNTAIVSVSDNHDIIANLPNQTYAKLSNYDEVREMNRQNVDVESVE
INFQSTKFENGFTLQDTPGVDSNVASHQSITEQYMYTSNMIFYTVDYNHVQSELNFKFMK
HINDVGIPVVFIINQIDKHQDDELSFSTFKSRVEKSIADWGIKLERIFYVSKFDHPENEL
EVLSTYLVSLDQHRETIEDYTLRTVEYITEAQLDYIQSEIQEVLEDLGIEEAEFEQAFLN
SQQHQAISEEAQLLNNPDELMAFLKNKRKNILENAYIMPHNMREMLRSYLESMSQDFNVG
GFFNKKKKKLQIQQQRLLTATDALQEHVNQQIRQPMREDMSFVTRFINKKEASDKVLNQH
YDVKSEMIEALYQPQTSISNTYVLTFSDEVVKAIKKYVEQQSTPIFKEIIENVQADELPT
EESDDLKEYQRYTELNELRQSLTTKNYRHYYIHLDESLDKLVDRQETTYQVATDNAQGNR
DNQQLNQNTATTNMSIDIQKALDIISDVPLFKRTKQDIHETLTRIDNKLIKIGVFGTFSA
GKSSLINALLGEHILVSSPNPTTAATTEISYGDESYITLKSQSQLLDEINAVVEYQDISF
STIEDFINSDLEKLKSHLNKNQLAFVHAVEKHYKLYVSMLENGEKHAINQQELKKWSAED
EYATFVKTVHIALMHDWLKGKIIVDSLGLHSNNQRHTNETEQILTSSDLILYVSYFNHSF
TDNDKAFIEHMKDMNQLNENQAFKMVINAADLAESQDDLEAVETYVSDALRQVHLQSDIF
AVSSRNALQAEDKGIDQLKQSIQQFVDVDSKSILEQQMIHQLQQMDRSYVEMITEFETNK
ADISRRQQRLTDYKDKQRLQHQLIDATLQHTDNEVEEQVYHLNARLKLQLLDDVKSVFNS
QMTQNSDFNEEKKVSTKVYLDQIHQRLFLEQSLITERIKKYFNKQLTEQIAPIVQQLADL
HVIVNPQFNFESANIEQPLLHIDFNDMLNALPKQLTKRKILNPNGQRDIHESICQSTLGL
LQPQMGLLRQQLELYVKQMAVEAESQFESFEANIQTQINDLLAFDLDTTLINQLKDKHQQ
LKTILY
>CIEIPNNI_00006 5'-3' exonuclease
MPNKILLVDGMALLFRHFYATSLHKQFMYNSQGVPTNGIQGFVRHIFSAIHEIRPTHVAV
CWDMGQSTFRNDMFDGYKQNRSAPPEELIPQFDYVKEISEQFGFVNIGVKNYEADDVIGT
LAQQYSTDNDVYIITGDKDLLQCINDNVEVWLIKKGFNIYNRYTLHRFNEEYDLEPQQLI
DIKAFMGDTADGYAGVKGIGEKTAIKLIQQYQSVENVVENIDALSAGQRNKINDNLDELY
LSKRLAEIHTQVPIDSEALFEKMSFATTLNHILSICNEHELHVSGKYISSHF
>CIEIPNNI_00007 Alanine dehydrogenase 1
MLVAVVKELKQGEGRVACTPENVRKLTDAGHKVIVEKNAGIGSGFSDDMYEKEGAKIVTH
EQAWEADLVIKVKEPHTSEYQYFKKDQIIWGFLHLASSKEIVEKMQEVGVTAISGETIIK
NGKAELLAPMSAIAGQRSAIMGAYYSEAQHGGQGTLVTGVHENVDIPGSTYVIFGGGVAA
TNAANVALGLNAKVIIIELNDDRIKYLQDMYAEKDVTVVKSTPENLAEQIKKADVFISTI
LIPGAKPPKLVTREMVKSMKKGSVLIDIAIDQGGTIETIRPTTISDPVYEEEGVIHYGVP
NQPGAVPRTSTMALAQGNIDYILEICDKGLEQAIKDNEALSTGVNIYQGQVTNQGLATSH
DLDYKEILNVIE
>CIEIPNNI_00008 L-threonine dehydratase catabolic TdcB
MTTNTVTLQTAHIVSLGDIEEAKASIKPFIRRTPLIKSMYLSQSITKGNVFLKLENMQFT
GSFKFRGASNKINHLTDEQKEKGIIAASAGNHAQGVALTAKLLGIDATIVMPETAPQAKQ
QATKGYGAKVILKGKNFNETRLYMEELAKENGMTIVHPYDDKFVMAGQGTIGLEILDDIW
NVNTVIVPVGGGGLIAGIATALKSFNPSIHIIGVQSENVHGMAESFYKRDLTEHRVDSTI
ADGCDVKVPGEQTYEVVKHLVDEFILVTEEEIEHAMKDLMQRAKIITEGAGALPTAAILS
GKINNKWLEDKNVVALVSGGNVDLTRVSGVIEHGLNIADTSKGVVG
>CIEIPNNI_00009 Serine/threonine exchanger SteT
MSNGKELQKNIGFFSAFAIVMGTVIGSGVFFKISNVTEVTGTAGMALFVWFLGGIITICA
GLTAAELAAAIPETGGLTKYIEYTYGDFWGFLSGWAQSFIYFPANVAALSIVFATQLINL
FHLSIGSLIPIAIASALSIVLINFLGSKAGGILQSVTLVIKLIPIIVIVIFGIFQSGDIT
FSLIPTTGNSGNGFFTAIGSGLLATMFAYDGWIHVGNVAGELKNPKRDLPLAISVGIGCI
MAVYLLINATFLLTLPIELLAGNLNAASDTSKILFGENGGKIITIGILISVYGTINGYTM
TGMRVPYAMAERKLLPFSHLFAKLTKSGAPWFGAIIQLIIAIIMMSMGAFDTITNMLIFV
IWLFYCMSFVAVIILRKREPNMERPYKVPLYPIIPLIAILAGSFVLINTLFTQFILAIIG
ILITALGIPVYYYKKKQKAA
>CIEIPNNI_00010 Quinolone resistance protein NorB
MDGLLINLKFYTLKSKTIQLFYRTDKFLLWNLSVFKSIGRQIEMEKPSREAFEGNNKLLI
GIVLSVITFWLFAQSLVNVVPILEDSFNTDIGTVNIAVSITALFSGMFVVGAGGLADKYG
RIKLTNIGIILNILGSLLIIISNIPLLLILGRLIQGLSAACIMPATLSIIKSYYIGKDRQ
RALSYWSIGSWGGSGVCSFFGGAVATLLGWRWIFILSIIISLIALFLIKGTPETKSKSIS
LNKFDIKGLVLLVIMLLSLNILITKGSELGVTSLLFITLLAIAIGSFSLFIVLEKRATNP
LIDFKLFKNKAYTGATASNFLLNGVAGTLIVANTFVQRGLGYSSLQAGSLSITYLVMVLI
MIRVGEKLLQTLGCKKPMLIGTGVLIVGECLISLTFLPEILYVICCVIGYLFFGLGLGIY
ATPSTDTAIANAPLEKVGVAAGIYKMASALGGAFGVALSGAVYAIVSNMTNIYTGAMIAL
WLNAGMGILSFVIILLLVPKQNDTQL
>CIEIPNNI_00011 Extracellular matrix-binding protein ebh
MNYRDKIQKFSIRKYTVGTFSTVIATLVFLGFNTSQAHAAETNQPASVVKQKQQSNNEQT
ENRESQVQNSQNSQNGQSLSATHENEQPNINQTNHVDVSAEQSSTTENEQAVSQNKQTKK
DTADATPTQSAKAESKHEQNESRSANKKENDNKAAHVENHEANVVTASDSPDNGNVQHDR
NELQAFFDANYHDYRFIDRENADSGTFNYVKGIFDKINTLLGSNDPINNKDLQLAYKELE
QAVALIRTMPQRQQTSRRSSRIQTRSVESRAAEPRSVSSYQNADSSYYVENANDGSGYPV
GTYINASNKGAPFYLPTAPWNTLKASAAKEIVLITAKQTGDGYQWVIKFNKGHAPHENMI
FWFALPSDQVPVGRTDFVTVNADGTNVQWSNGAGAGAYKPLPQMWPYGVNDSRSRDFKIR
NRSGQVIYDWTDVHVNTLRDLARAGDYFSEAGAPAATKAIGEQTFRYINGERPTESPGAS
KVYTFIGAGDASYTISFKTQGPTTNKLYYAAGGRALEYNQLFMYSQLYVESTQDHQQRLD
GFRQVVNRSYRLDTTKRVEVSQGNIQTKKVLESTNLNIDDFMDDPLSYVKTPSNKVLGFY
PTNANPNAYRHGGTNPLNEYQLSQLFTDDKLQQAARTGNPIRLMIGFDYPDGHGNAETLV
PVNLTVLPEIQHNIKFYKNDDTQNIADKPASRQAGHPIFYVYAGNQGNASVNLGGSVTSI
QPLRINLTSSENFTDRDWQITGIPRTLHIENSTNRPNNARERNIELVGNLLPGDYFGTIR
FGRKEQLFEIRVKPHTPTITTTAEQLRGTALQKVPITVTNIPLDPSSLVYIVYPTDQTRD
GGSEADQMPSNYSILATGTPDGVHNTITIQPKDYTVFIPPVGKQIRALIYYNKVVASNMS
NAVTILPDDIPPTINNPVGLNAKYYRGDEVNFTMGVSDRHSGIKNTTITTLPNGWTSNLT
KADKNNGSLSITGRVSMNQAFNSDITFKVSATDNVNNTTNDSQSKHVTVHVGKISEDAHP
IVLANSEKVVVVNPTSVSNDEKQRIITAFMNKNQNIRGYLASSNPVTVDNNGNVTLHYRD
GSSTTLDATNVMTYEPVVKPEYQTANAPKTATVTIAKGQSFSIGDIKQYFTLSNGQAIPN
GTFTNITSDRTIPTAQEVSQMNAGTQLYHIVASNAYHKDTEDLYISLKIIDVKQPEGDQR
VYRTSTYDLTTDEISKVKQAFINANRDAITFAEGDISVTNTPNGANVSTVTVNINKGRLT
KSFTSNLANMNFLRWVNFPQDYTVSWTNAKIASRPTDGGLSWSDDHKSLIYRYDATLGTP
ITTNDILTMLKATTTVPGLRNNIAGNEKTQAEAGGRPNYRPTGYSQANASSDGQRQYTLN
GQVIQVLDIINPTNGFGGQTITNSNVRANHSNSTVVSVNEPAANGAGAFTIDHVVKNNTT
HNAADAVYKAQLYLSPYGPKQYVEHLNQNTGNTTDAINIYFVPSDLVNPTISVGNYANHQ
VFSGETFTNTITANDNFGVQSVTVPNTSQITGTVDNNHQHVSATAPNVTSATNKTINLVA
TDTSGNTATTSYNVTIKPLRDKYRVGTSSTAANPVRIANISNNAIVSQADQTAIINSLTF
TETVPNRSYARASANEITSKTVSNVSRTGNNANVTVTVTYQDGTTSTVTVPVKHVIPEIV
AHSHYTVQGQDFPAGNGSSASDYFKLSNGSAIPDATITWVSGQAPNKDNTRIGEDITVTA
HILIDGETTPITKTATYKVVRTVPKHVFETDRGVLYPGVSDMYDAKQYVKPVNNSWSTNA
QNMNFQFVGTYGPNKDVVGISTRLIRITYDNRQTEELTILSKVKPDPPRIDGNSVTYKAG
LTNQEVKVNNVLSNSTVKLFKADNTPLNVTNIIHGSGYSSVVTVSDALPNGGIKAKSSIS
MNNVTYTTQDEHGQVVTVTRNESVDSNDSASVTVTPQLQATTEGAVFIKGGDGFDFGHVE
RFIQNPPHGATVAWHDNPDTWKNTVGNTHKTAVVTLPSGQGTRNVEVPVKVYPVANAKAL
SRDVKGQNLTNGTDAMSYITFDPNTNTNGITAAWANRQQPNNQQAGVQHLNVDVTYPGIS
AAKRVPVTVNVYQFEFPQTTYTTTVGGTLASGTQASGYAHMQNATGLPTDGFTYKWNNAA
TGTNDANWAAMNKPNAAKVVNAKYDVIYNGHTFATSLPAKFVVKDVQPAKPTVTETAAGA
ITIAPGANQTVNTHAGNVTTYADKLVIKRNGSVVTTFTRHNNTSPWVKEASATNVTGIVG
TNNGITVAAGTFNPADTIQFVATQGSGETISDEQRSDDFTVVAPQPNQATTKIWQNGHID
ITPNNPSGHLINPTQAMDIAYTEKVGNGAEHSKTINVVRGQNNQWTIANKPDYVTLDAQT
GKVTFNANTIKPNSAITITPKAGTGHSASSNPSTLTAPAAHTVNTTEIVKDYGSNVTASE
INNAVQVANKRTATIKNGTAMPTNLAGGSTTTIPVTVTYNDGSTEEVQESIFTKADKREL
ITAKNHLDDPVSTDGKKPGTITQYNNAMHNAQQQINAAKTEAQQVINNERATPQQVNAAL
SKVQAAQTKINEAKALLQNKEDNSQLVTSKNNLQSSVNQVPSTAGMTQQSIDNYNAKKRE
AESEITAAQRIIDNGDATAQQISDEKHRVDNALTALNQAKHDLTADTHALEQAVQQLNRT
GTTTGKKPASITAYNNSIRALQSDLTSAKNSANAIIQKPIRTVQEVQSALTNVNRVNERL
TQAINQLVPLADNSTLRTAKTKLDEEINKSVTTDGMTQSSIQAYENAKRAGQTESTNAQN
VINNGDATDQQIAAEKAKVEEKYNSLKQAIAGLTPDLAPLQTAKTQLQNDIDQPTSTTGM
TSASVATFNEKLSAARTKIQEINRVLASHPDVATIRQNVTAANAAKSALDQARNGLTVDK
APLENAKNQLQHSIDTQTSTTGMTQDSINAYNAKLTAARNKIQQINQVLAGSPTVDQINT
NTSAANQAKSDLDHARQALTPDKTPLQNAKTQLEQSINQPTDTTGMTTASLNAYNQKLQA
ARQKLTEINQVLNGNPTVQNINDKVAEANQAKDQLNTARQGLTLDRQPALTTLHGASNLN
QAQQNNFTQQINAAQNHAALETIKSNITALNTAMTKLKESVADNNSIKSGQNYTDATQAN
KQAYDNAVNAAKGVIGETNNPTMDVNTVNQKAASVKSTKDALDGQQNLQRAKTEATNAIT
HASDLNQAQKNALTQQVNSAQNVQAVNNIKQTTQSLNTAMTGLKRGVANHNQVVQSDNYV
NADTNKKNDYNNAYNHANDIINGNPQHPVITPSDVNNALSNVTSKEHALNGEAKLNTAKQ
EANTALGQLNNLNNAQRQNLQSQINGAHQIETVNTIKQNATNLNSAMGNLRHAVADKEQV
KRTEDYADADTAKQNAYNSAVSSAETIINQSTNPTMSVDDVNRATSAVTTNKTALNGDEK
LAQSKTDAARAIDALPHLNNAQKADVKSKINAASNIAGVNTVKQQGTDLNTAMGNLQGAI
NDEQTTLNSQNYQDATPSKKTAYTNAVQAAKDILNKSNGQNKTKDQVTEAMNQVNSAKNN
LDGTRLLDQAKQTAKQQLNNMTHLTTAQKTNLTNQINSGTTVAGVHTVQSNANTLDQAMN
TLRQSIANKDATKASEDYVDANNDKQTAYNNAVAAAETIINANSNPEMNPSTITQKAEQV
NSSKTALNGDENLATAKQNAKTYLNTLTSITDAQKNNLISQISSATRVSGVDTVKQNAQH
LDQAMASLQNGINNESQVKSSEKYRDADTNKQQEYDNAITAAKAILNKSTGPNTAQNAVE
AALQRVNTAKDALNGDAKLIAAQNAAKQHLGTLTHITTAQRNDLTNQISQATNLAGVESV
KQSANSLDGAMGNLQTAINDKSGTLASQNFLDADEQKRNAYNQAVSNAETILNKQTGPNT
AKTAVEQALNNVNSAKHALNGTQNLNNAKQAAITAINGASDLNQKQKDVLKAQANGAQRV
SNAQDVQRNATELNTAMGTLKHAIADKTNTLASSKYVNADSTKQNAYTTKVTNAEHIISG
TPTVVTTPSEVTAAANQVNSAKQELNGDERLRVAKQNANTAIDALTQLNTPQKAKLKEQV
GQANRLEDVQTVQTNGQSLNNAMKGLRDSIANETTVKASQNYTDASPNNQSTYNSAVSNA
KGIINQTNNPTMDTSAITQATTQVNNAKNGLNGAENLRNAQNTAKQNLNTLSHLTNNQKS
AISSQIDRAGHVSEVTAAKNAATELNTQMGNLEQAIHDQNTVKQSVNFTDADKAKRDAYT
NAVSRAETILNKTQGANTSKQDVEAAIQSVTSAKNALNGDQNVTNAKNTAKHALNNLTSI
NNAQKRNLTTKIDQATTVAGVEAVSNTGTQLNTAMANLQNGINDKTNTLASENYHDADSD
KKTAYTQAVTNAENILNKNSGSNLDKVAVENALSQVTNAKGALNGNHNLEQAKSNANTTI
NGLQHLTTAQKDKLKQQVQQAQNVAGVDTVKSSANTLNGAMGTLRNSIQDNTGTKNGQNY
LDATESNKTNYNNAVDRANGVINATSNPNMDANAINQIATQVTSTKNALDGTHNLTQAKQ
TATNAIDGATNLNKAQKDALKAQVTSAQRVANVTSIQQTANELNTAMGQLQHGIDDENAT
KQTQKYRDAEQNKKTAYDQAVAAAKAILNKQTGSNSDKAAVDHALQQVTSTKDALNGDAK
LAEAKAAAKQNLGTLNHITNAQRTALEGQINQATTVDGVNTVKTNANTLDGAMNSLQGSI
NDKDATLRNQNYLDADESKRNAYTQAVTAAEGILNKQTGGNTSKADVDNALNAVTRAKAA
LNGADNLRNAKTSATNTINGLPHLTQLQKDNLKHQVEQAQNVAGVNGVKDKGNTLNTAMG
ALRTSIQNDNTTKTSQNYLDASDSNKNNYNTAVNNANGVINATNNPNMDANAINGMANQV
NTTKAALNGAQNLAQAKTNATNTINNAHDLNQKQKDALKTQVNNAQRVSDANNVQRTATE
LNSAMTALKAAIADKERTKASGNYVNADQEKRQAYDSKVTNAENIISGTPNATLTVNDVN
SAASQVNAAKTALNGDNNLRVAKEHANNTIDGLAQLNNAQKAKLKEQVQSATTLDGVQTV
KNSSQTLNTAMKGLRDSIANEATIKAGQNYTDASPNNRNEYDSAVTAAKAIINQTSNPTM
EPNTITQATSQVTTKEHALNGAQNLAQAKTTAKNNLNNLTSINNAQKDALTRSIDGATTV
AGVNQETAKATELNNAMHSLQNGINDETQTKQTQKYLDAEPSKKSAYDQAVNAAKAILTK
ASGQNVDKAAVEQALQNVNSTKTALNGDAKLNEAKAAAKQTLGTLTHINNAQRTALDNEI
TQATNVEGVNTVKAKAQQLDGAMGQLETSIRDKDTTLQSQNYQDADDAKRTAYSQAVNAA
ATILNKTAGGNTPKADVERAMQAVTQANTALNGIQNLERAKQAANTAITNASDLNTKQKE
ALKAQVTSAGRVSAANGVEHTATELNTAMTALKRAIADKAETKASGNYVNVDANKRQAYD
EKVTAAENIVSGTPTPTLTPSDVTNAATQVTNAKTQLNGNHNLEVAKQNANTAIDGLTSL
NGPQKAKLKEQVGQATTLPNVQTVRDNAQTLNTAMKGLRESIANEATIKADQNYTDASQS
KQTDYNNAVTAAKAIIGQTTSPTMNAQEINQAKDQVTAKQQALNGQENLRTAQTNAKQHL
NGLSDLTNAQKEAAKRQIEGATHVNEVTQAQNNADALNTAMTNLKNGIQDQNTIKRGVNF
TDADEAKRNAYTNAVTQAEQILNKAQGPNTAKDGVETALQNVQRAKNDLNGNQNVANAKT
TAKNALNNLTSINNAQKEALKSQIEGATTVAGVNQVSTTASELNTAMSNLQRGINDEAAT
KAAQKYTDADREKQTAYNDAVTAAKTLLNKTAGSNDNKAAVEQALQRVNTAKNALNGDAR
LNEAKKTAKQQLATMSHLTDAQKANLTSQIERGTTVAGVQGIQANAGTLNQAMNQLRQSI
ASKDATKSSEDYQDANTDLQNAYNRAVSDAEGIISATNNPEMNPDTINQKASQVNSAKSA
LNGDEKLAAAKQTAKTDIGRLTDLNNAQRTAANAEVDQAPNLAAVTAAKNKATSLNTAMG
NLKHALAEKDNTKRSVNYTDADRPKQQAYDTAVTQAEAITNANGSNANETQVQAALNQLN
QAKNDLNGDNKVAQAKEAAKRALASYNNLNNAQSIAATSQIDNATTVAGVTAAQNTANEL
NTAMGQLQNSINDQNTVKQQVNFTDADQGKKDAYTNAVTNAQGILDKAHGQNMTKAQVEA
ALNQVTTAKNALNGDANVRQAKSDAKANLGTLTHLNNAQKQDLTSQIEGATTVNGVNGVK
TKAQDLDGAMQRLESAIANKDQTRASENYIDADPTKKTAFDNAITQAESYLNKDHGANKD
KQAVEQAIQSVTTAKNALNGDANLQRAKTEATQAIDNLTHLNTPQKTALKQQVNAAQRVS
GVTDLKNSATSLNNAMDQLKQAIADHDTIVAGGNYTNASPDKQGAYTDAYNAAKNIVNGS
PNVVTNAADVTAATQRVNNAETGLNGDSNLATAKQQAKDALRQMTHLSAAQKQSITGQID
SATQVTGVQSVKDNATNLDNAMNQLRNSIANKDEVKASQPYVDADTDKQNAYNTAVTSAE
NIINATSQPTLDPSAVTQAANQVNTNKTALNGVQNLANKKQETTANINQLSHLNNAQKQD
LNTQVTNAPNISTVNQVKTKAEQLDQAMERLINGIQDKDQVKQSVNFTDADPEKQTAYNN
AVTAAENIINQANGTNANQSQVEAALSTVTTTKQALNGNRKVTDAKNNANQTLSTLDNLN
NAQKGAVTGNINQAHTVAEVTQAIQTAQELNTAMGNLKNSLNDKDTTLGSQNFADADPEK
KNAYNEAVHNAENILNKSTGTNVPKDQVEAAMNQVNTTKAALNGTQNLEKAKQHANTAID
GLSHLTNAQKDALKQLVQQSTTVAEAQGNEQKANNVDAAMDKLRQSIADNATTKQNQNYT
DASPNKKDAYNNAVTTAQGIIDQTTSPTLDPTVINQAAGQVSTTKNALNGNENLEAAKQQ
ATQSLGSLDNLNNAQKQTVTDQINGAHTVDEANQIKQNAQNLNTAMGNLKQAIADKDATK
ATVNFTDADQAKQQAYNTAVTNAENIISKANGGNATQTEVEQAIQQVNAAKQALNGNANV
QHAKDEATALINSSNDLNQAQKDALKQQVQNATTVAGVNNVKQTAQELNNAMTQLKQGIA
DKEQTKADGNFVNADPDKQNAYNQAVAKAEALISGTPDVVVTPSEITAALNKVTQAKNDL
NGNTNLATAKQNVQQAIDQLPNLNQAQRDEYNKQITQATLVPNVNAIQQAATTLNDAMTQ
LKQGIANKAQIKGSENYHDADTDKQTAYDNAVTKAEELLKQTTNPTMDPNTIQQALTKVN
DTNQALNGNQKLADAKQAAKTNLGTLDHLNDAQKQALTTQVEQAPDIATVNNVKQNAQNL
NNAMTNLNNALQDKTETLNSINFTDADQAKKDAYTNAVAHAEGILSKANGSNASQTEVEQ
AIQRVNEAKQALNGNDNVQRAKDAAKQVITNANDLNQAQKDALKQQVDAAQTVANVNTIK
QTAQDLNQAMTQLKQGIADKDQTKANGNFVNADTDKQNAYNNAVAHAEQIISGTPNANVD
PQQVAQALQQVTQAKGDLNGNHNLQVAKDNANTAIDQLPNLNQPQKTALKDQVSHAELVT
GVNAIKQNADALNNAMGTLKQQIQANSQVPQSVDFTQADQDKQQAYNNAANQAQQIANGT
PTPVLSPDTVTQAVTTMNQAKDALNGDEKLAQAKQDALANLDTLRDLNQPQRDALRNQIN
QAQALATVEQTKQNAQNVNATMGNLKQGIANKDTVKASENYHDADADKQTAYTNAVSQAE
GIINQTTNPTLNPDEITRALTQVTDAKNGLNGEAKLATEKQNAKDAVSGMTHLNDAQKQA
LKGQIDQSPEIATVNQVKQTATSLDHAMDQLSQAINDKAQTLADGNYLNADPDKQNAYKQ
AVAKAEALLNKQSGTNEVQAQVESITNEVKTAKQALNGNDNLANAKQQAKQQLANLTHLN
DAQKQSFENQITQAPLVTDVTTINQKAQTLDHAMELLRNSIADNQATLASEDYHDATAQR
QNDYNQAVTAANNIINQTTSPTMNPDDVNRATTQVNNTKVALDGDENLVAAKQQANNRLD
QLDHLNNAQKQQLQSQITQSSDIAAVNGHKQTAESLNTAMGNLINAIADHQAVEQRGNFI
NADTDKQTAYTTAVNEAEAMINKQTGQNANQTEVEQAITKVQTTLQALNGDHNLQVAKTN
ATQAIDALTSLNDPQKTALKDQVTAATLVTAVHQIEQTANTLNQAMHGLRESIQDNATTQ
ANSKYINEDQPEQQNYDQAVQAANNIINEQTATLDNNAINQAATTVNTTKAALHGDVKLQ
NDKDRAKQTVSQLAHLNNAQKHMEDTLIDSETTRTAVNHDLTEAQALDQLMDTLQQSIAD
KDATRASSAYVNAEPNKKQAYDEAVQNAESIIAGLTNPTINKGNVSSATQAVTSSKNALD
GVERLAQDKQTAGNSLNHLDQLTPAQQQALENQINNATTRDKVAEIIAQAQALNEAMKAL
KESIKDQPQTEASSKFINEDQAQKDAYTQAVQHAKDLINKTTDPTLAKSIIDQATQAVTD
AKNNLHGDQKLAQDKQRATETLNNLSNLNTPQRQALENQINNAATRDEVAQKLTEAQALN
QAMEALRNSIQDQQQTEAGSKFINEDKPQKDAYQAAVQHAKDLINQTSNPTLDKAQVEQL
TQAVNQAKDNLHGDQKLADDKQHAVTDLNQLNGLNNPQRQALESQINNAATRGEVAQKLT
EAQALNQAMEALRNSIQDQQQTESGSKFINEDKPQKDAYQAAVQNAKDLINQTGNPTLDK
SQVEQLTQAVTTAKDNLHGDQKLARDQQQAVTTVNALPNLNHAQQQALTDAINAAPTRTE
VAQHVQTATELDHAMETLKNKVDQVKTDKAQPNYTEASTDKKEAVDQALQAAQSITEPNN
GSNANKDAVEQALTKLQEKENELNGNERVAEAKTQAKQTVDQLTHLNADQIATAKQNIDQ
AMKLQPIA
>CIEIPNNI_00012 Extracellular matrix-binding protein EbhA
MDQLQQAVNDHTNVEQTVDYTQADSDKQNAYKQAIADAENVLKQNANKEQVDQALQNILN
AKQALNGDERVALAKTNGKHDIDQLNTLNNAQQDGFKGRIDQSNDLNEIKQIVDEAKALN
RAMNQLSQEITGNEGRTKGSTNYVNADTQVKRVYDDAVDKAKEALNKATGQNLTAEEVIK
LNDAVTAAKQALNGEERLNKRKSEALQRLDQLTHLNNAQRQLATQQINNAETLNKASRAI
NRAVQLDDAMGAVQQYIDDHHFDVISSTNYINADDNLKANYDNAITNAAHELDKVQGSAI
TKAEAEQLKQNIIDAQQALNGDQNLATAKDKANAFVDTLNGLNQQQQDLAHQAINNADTV
TGIANIINDQIDLNNAMETLKHLVDNEIPTAEQTINYQNADDVAKSIFDDAKRLANTLLN
SDNTNVNDINGAIQAVNDAIQNLNGDQRLQEAKDKAIQNVNKVLADKLKEIEASNATDQD
KLIAKNKAEELANSIINNINKATSNQDVSQVQTAGNHAIEQVHANEIPKAKIDANKDADK
QVQALIDEIDRNPNLTDKEKQALKDRINQILQQGHNGINNAMTKEEIEQAKAQLAQALQE
IKDLVKAKENAKQDVDKQVQALIDEIDRNPNLTDKEKQALKDRINQILQQGHNGINNAMT
KEEIEQAKAQLAQALQEIKDLVKAKENAKQDVDKQVQALIDEIDRNPNLTDKEKQALKDR
INQILQQGHNGINNAMTKEEIEQAKAQLAQALQEIKDLVKAKENAKNAIKALANAKRDQI
NSNPDLTPEQKAKALKEIDEAEKRALENIENAQTKDQLNQGLNLGLDDIRNTHVWEVDTQ
PAVNEIFDATPEQILVNGELIVHRDDIITEQDILAHINLVDQLTAEVIDTPSTATISDSL
TAKVEVTLLDGSKVIVNVPVKVVEKELAVVKQQAIESIENAAQQKINDINNHATLTPEQK
EAAIAEVNKLKQQAIEQINNATDVHSVEEVQQQEQTHIEQFNPEQFTIDQAKSNAIKSIT
DAIQHMIDEINASKDLTDKEKQEAISKLNQLKEQAIQAIQRAQSIDEITQQLEQFKAQIK
AANPFAKELEKRKKVAISKIKDISTDAIERIKNSSTGTAEERQAAMNRINEIVLETIRDI
NNAQTPQQVEAALNNGIARILAVQIVTSNNSKHSSDSDGESNSHISIGYGTVNHPFNSSA
IGHKKKLDQDDEIDPLHMRHFGDRIGNVIKNALGVVGISGLLASFWFFIAKRRRKEDEEE
ELEIRDNSKDKKKGSIEGTKHLPLLLAKRRRKEDEEDAIVEEKDSLNNNESLDKVKHTPF
FLPKRRRKEDEEDVEVTNENTDEKVLQDNEHSPLLIAKRRKDKEVDVETTPSIESNEDDA
PLLLAKKKNQKDNQSKGKKSASKKPSKKLVAKKKKKKSKKNKK
>CIEIPNNI_00013 14.7 kDa ribonuclease H-like protein
MAKINFDAATKGNPGISTCAVVIKEDDQHYTYTHELGEMDNHTAEWAACIYALKHARELN
VSNALLYTDSKLIADSVNAGYVKNAKFKPYFDQLEIFEQDFDLLFVKWIPREQNKEANQN
AQQALYKLIKKNK
>CIEIPNNI_00014 queuosine precursor transporter
MYNEILGLVTFIATFVLMVLMYRFFGKQGLIAWVAIGTIIANIQVIKTVEIFGISATLGN
VMFASIYLATDILNDIYGRRVAKRAVWLGFSSTLIMIIVMQLSLHFIPAPEDMAQKALHA
IFDVVPRIALGSIVAYIIGQHIDVFIFSLIKKVFSSDKTFFIRAYGSTFLSSIIDTALFV
AIAFIGSLPGTVVFEIFITTYVLKLASTVFNVPFGYIAKSFYRKGKIDKLDQGY
>CIEIPNNI_00015 hypothetical protein
MQYFEVIKEVSRILTFSEQNALAKIDDLMNTYCNQCPIKTRLRKLEGKTKSHHFCINECS
IGKEIKQLGNELQ
>CIEIPNNI_00016 hypothetical protein
MQIISISETPNHNTMKITLSESREGMTSDTYTKVDDSQPAFINDILKVEGVKSIFHVMDF
ISVDKENDANWETVLPKVEAVFE
>CIEIPNNI_00017 hypothetical protein
MEILRIEPTPSPNTMKVVLSYTREDKLSNTYKKVEENQPRFINQLLSIDGITSIFHVMNF
LAVDKAPKADWEVILPDIKAAFSGESQVLESGKDPQIDKHFGEIKAELLTFKGIPYQIKL
TSADQELREQLPQTYVDHMTQAQTEHDNIVFMRKWLDLGNRYGNIEEVMDGVLEEVLATY
PESQLPVLVKHALEENHAANNYHFYRHVSLDEYHATDNWKTRLRMLNHFPKPTFEDIPLL
DLALSDEKVPVRRQAIVLLGMIESKEILPYLYKGLRDKSPAVRRTAGDCISDLGYPEALP
EMVLLLDDSQKIVRWRAAMFIFDEGNAEQLPALKAHINDNAFEVKLQIEMAISRIENGDE
ALGSVWKQMANRTI
>CIEIPNNI_00018 hypothetical protein
MNAYDAYMKEIAQQMRGELTQNGFTSLETSEAVLEYMNQVNADDTTFVVINSTCGCAAGL
ARPAAVAVATQNEHRPTNTVTVFAGQDKEATATMREFIQQVPSSPSYALFKGQDLVYFMP
REFIEGRDINDIAMDLKDAFDENCK
>CIEIPNNI_00019 Thymidylate synthase
MITKCYIKLNYIKLNIHTINNENEVLSHMLNSFDAAYHSLCEEVLEIGNTRNDRTNTGTI
SKFGHQLRFDLSKGFPLLTTKKVSFKLVATELLWFIKGDTNIQYLLKYNNNIWNEWAFEN
YIKSDEYKGPDMTDFGHRALSDPEFNEQYKEQMKQFKQRILEDDTFAKQFGDLGNVYGKQ
WRDWVDKDGNHFDQLKTVIEQIKHNPDSRRHIVSAWNPTEIDTMALPPCHTMFQFYVQDG
KLSCQLYQRSADIFLGVPYNIASYALLTHLIAKECGLEVGEFVHTFGDAHIYSNHIDAIQ
TQLARESFNPPTLKINSDKSIFDINYEDLEIVDYESHPAIKAPIAV
>CIEIPNNI_00020 Dihydrofolate reductase
MTLSILVAHDLQRVIGFENQLPWHLPNDLKHVKKLSTGHTLVMGRKTFESIGKPLPNRRN
VVLTSDTSFNVEGVDVIHSIEDIYQLPGHVFIFGGQTLFEEMIDKVDDMYITVIEGKFRG
DTFFPPYTFEDWEVTSSVEGKLDEKNTIPHTFLHLIRKK
>CIEIPNNI_00021 DegV domain-containing protein
MTKQIIVTDSTSDLSKEYLEANNIHVIPLSLTIEGVSYVDQVDITSEEFINHIENDEDVK
TSQPAIGEFISAYEELGKDGSEIISIHLSSGLSGTYNTAYQASQMVDANVTVIDSKSISF
GLGYQIQHLVELVKEGVSTSEIVKKLNHLRENIKLFVVIGQLNQLIKGGRISKTKGLIGN
LMKIKPIGTLDDGRLELVHNARTQNSSIQYLKKEIAEFIGDHEIKSVGVTHANVIEYVDK
LKKVFNEAFHVNNYDINVTTPVISAHTGQGAIGLVVLKK
>CIEIPNNI_00022 Peptide methionine sulfoxide reductase MsrA 2
MTKEYATLAGGCFWCMVKPFTSYPGIKSVVSGYSGGHVDNPTYEQVCTNQTGHVEAVQIT
FDPEVTSFENILDIYFKTFDPTDDQGQFFDRGESYQPVIFYHDEHQKKAAEFKKQQLNEQ
GIFKKPVITPIKPYKNFYPAEDYHQDYYKKNPVHYYQYQRGSGRKAFIESHWGNQNA
>CIEIPNNI_00023 Peptide methionine sulfoxide reductase MsrB
MLKKDKSELTDIEYIVTQENGTEPPFMNEYWNHFAKGIYVDKISGKPLFTSEEKFHSECG
WPSFSKALDDDEIIELVDKSFGMVRTEVRSEESNSHLGHVFNDGPKESGGLRYCINSAAI
QFIPYEKLEELGYGDLISHFDK
>CIEIPNNI_00024 PTS system glucose-specific EIIA component
MFKKLFGKGKEVQKDIAIYAPLTGEYVKIEDIPDPVFAQKMMGEGFGINPTEGEVVSPIA
GRVDNVFPTKHAIGLKADNGLELLVHIGLDTVQLDGEGFEVLVSSGDEVNVGDPLVRFNL
EFINNNAKSVISPIIITNTDQAASINIYDENAVIKGETKVIDVTMN
>CIEIPNNI_00025 hypothetical protein
MKNYSFYQFVMTVRGRHDDKGRLAEEIFDDLAFPKHDDDFNILSDYIETHGDFTLPMSVF
DDLYEEYTEWLKF
>CIEIPNNI_00026 putative CtpA-like serine protease
MDDKQHTSSSDDERAEIATSNQDQQTNSSKRVHLKRWQFISILIGTILITAVITVVAYIF
INQKISGLNKTDQANLNKIENVYKILNSDYYKKQDSDKLSKAAIDGMVKELKDPYSEYLT
KEQTKSFNEGVSGDFVGIGAEMQKKNDQIMVTSPMKGSPAERAGIRPKDVITKVNGKSIK
GKALDEVVKDVRGKENTEVTLTVQRGSEEKDVKIKREKIHVKSVEYKKKDKVGVITINKF
QNDTSGELKDAVLKAHKDGLKKIVLDLRNNPGGLLDEAVKMANIFIDKGKTVVKLEKGKD
TEAIQTSNDSLKEAKDMDISILVNEGSASASEVFTGALKDYNKAKVYGSKTFGKGVVQTT
REFKDGSLLKYTEMKWLTPDGHYIHGKGIKPDVTIDTPKYQSLNVIPNTKTFKVGDDDKN
IKTIKIGLSALGYKVDNESTQFDQALENQVKAFQQTNKLEVTGEFNKETNNKFTELLVEK
ANKHDDVLDKLINILK
>CIEIPNNI_00027 hypothetical protein
MIRLGKMSDLDQILNLVEEAKELMKEHDNEQWDDQYPLLEHFEEDIAKDYLYVLEENNKI
YGFIVVDQDQAEWYDDIDWPVNREGAFVIHRLTGSKEYKGAATELFNYVIDVVKARGAEV
ILTDTFALNKPAQGLFAKFGFHKVGEQLMEYPPYDKGEPFYAYYKNLKE
>CIEIPNNI_00028 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKKIAFTGGGTVGHVSVNLSLIPTALSQGYEALYIGSKNGIEREMIESQLPEIKYYPISS
GKLRRYISLENAKDVFKVLKGILDARKVLKKEKPDLLFSKGGFVSVPVVIAAKSLNIPTI
IHESDLTPGLANKIALKFAKKIYTTFEETLNYLPKEKADFIGATIREDLKNGNAHNGYQL
TGFNENKKVLLVMGGSLGSKKLNSIIRENLDALLQQYQVIHLTGKGLKDAQVKKSGYIQY
EFVKEELTDLLAITDTVISRAGSNAIYEFLTLRIPMLLVPLGLDQSRGDQIDNANHFADK
GYAKAIDEEQLTAQILLQELNEMEQERTRIINNMKSYEQSYTKEALFDKMIKDALN
>CIEIPNNI_00029 hypothetical protein
MSQWKRISLLIVFTLVFGIIAFFHESRLGKWIDNEVYEFIYSSESFITTSIMLGATKVGE
VWAMLCISLLLVAYLMLKRHKIEALFFALTMALSGILNPVLKNIFDRERPTLLRLIDITG
FSFPSGHAMGSTAYFGSGIYLLKRLNQGNSKGILIGLCAAMILLISISRVYLGVHYPTDI
IAGIIGGVFCIILSTLLLRNKLIN
>CIEIPNNI_00030 hypothetical protein
MTNPTRTKRCGGDVLCGIDNHFQLLLYISENHCQLETKTFFEYFLRIVNKTHDYAILENK
KICISH
>CIEIPNNI_00031 Response regulator ArlR
MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSING
LEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQP
QKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYN
SEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR
>CIEIPNNI_00032 Signal transduction histidine-protein kinase ArlS
MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKT
VKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGI
EYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQI
TKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDA
SHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVND
ISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAI
KYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLG
LSIAQKIIQLNGGSIKIKSEINKGTTFKIIF
